Encephalitis, Reversible Splenial Lesions, and COVID-19

Rujittika Mungmunpuntipantip, Viroj Wiwanitkit

DOI: 10.4274/tnd.2021.90093

Issue: 2021, Volume 27 - Supplement 1
0 350

Pandemic-Triggered Aberrant Drug Use may Cause Failure of Antiepileptic Therapy

Manolya Bergüzar Şekerlisoy, Aslıhan Taşkıran Sağ

DOI: 10.4274/tnd.2021.45804

Issue: 2021, Volume 27 - Supplement 1
0 348

Guillain-Barré Syndrome and COVID-19 Vaccines: A Comment

Joob Beuy, Viroj Wiwanitkit

DOI: 10.4274/tnd.2021.47048

Issue: 2021, Volume 27 - Supplement 1
0 381

Assesment of quality of life in neurological diseases

Sibel Karşıdağ, Yasemin Ekmekyapar Fırat, Fettah Eren, Sibel Canbaz Kabay, Murat Terzi

DOI: 10.4274/tnd.2023.56649

Issue: 2024, Volume 30 - Issue 1
1919 979

A rare variant of Guillain-Barré syndrome: Isolated bilateral facial paralysis

Saniye Karabudak, Zeliha Matur, Aslı Yaman Kula, Vildan Güzel, Ferda İlgen Uslu

DOI: 10.55697/tnd.2024.151

Issue: 2024, Volume 30 - Issue 4
438 344

Characteristics of ischemic stroke during the COVID-19 pandemic

Mehmet Yalman, Fatma Münevver Gökyiğit, Zahide Mail Gürkan, Ridvan Yazgu

DOI: 10.55697/tnd.2025.253

Issue: 2025, Volume 31 - Issue 1
77 69